Researchers at Johns Hopkins University say they discovered an advanced method Cancer detection.
A new study published in the journal Cancer Discovery and partially funded by the National Institutes of Health found that genetic material excreted by tumors can be detected in the bloodstream. Cancer diagnosis.
According to a press release, the researchers analyzed plasma samples from the large-scale atherosclerosis risk of a community (ARIC) study to assess risk factors for heart attacks, strokes, heart failure and other cardiovascular diseases.
FDA approves first AI tools to predict breast cancer risk
We analyzed 26 participants diagnosed with cancer within 6 months of sample collection and 26 blood samples that were not diagnosed with cancer.
Of these 52 participants, 8 participants scored aggressively on the Multicancer Early Detection (MCED) lab test and were diagnosed with cancer within 4 months of blood collection.
MCED testing is an experimental type of cancer screening that is searching for multiple types of cancer simultaneously, according to the American Cancer Society. These signs may include fragments of DNA, RNA, or protein from abnormal cells.
Click here to sign up for our health newsletter
For six of these eight individuals, the researchers were able to evaluate additional blood samples collected 3.1-3.5 years ago.
With four samples, Identified by researchers Tumor-derived mutations (genetic changes within cancer cells).
Lead study author Yuxuan Wang, MD, PhD, and assistant professor of oncology at Johns Hopkins University School of Medicine, shared in a statement that investigators were surprised by the results.
“We’ll provide time for intervention three years ago,” she said. “Tumor progress will be much lower and likely to be more likely Easy to cure. ”
Visit us for more health articles www.foxnews.com/health
Clayton Clayton Clayton Bert Wogelstein, MD, professor of oncology at the Ludwig Centre at Johns Hopkins’s Ludwig Centre, said the study “sets the benchmark sensitivity needed for success, with the promise of MCED testing in cancer detection very quickly.”
Detecting cancer several years before clinical diagnosis could “help to provide management for more.” Favorable results“Dr. Nicholas Papadopoulos, senior author, professor of oncology and investigator at the Ludwig Centre.
“Of course, after a positive test for such cancer, we need to decide on appropriate clinical follow-up,” he added.
Fox News Digital reached out to Johns Hopkins for comment.
